Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.

UNLABELLED In vitro studies of ocular bioavailability of active pharmaceutical ingredients (API) from colloidal drug delivery systems do not consider physiological shear stress generated by eyelid wiping and tear flow. The present study introduces a live cell imaging approach which enables the investigation of model drug uptake from various formulations under shear stress by using custom-made microchannels for the cultivation of human corneal epithelial cells (HCE-T). Coumarin-6 (C-6) was used as a model API incorporated into solid lipid nanoparticles and liposomes, and as an aqueous crystalline suspension. Confocal laser scanning microscopy visualized C-6 uptake into HCE-T cells in a time-resolved manner with an applied shear stress of 0.1 Pa. Static conditions were also studied for comparative purposes. Additionally, solid lipid nanoparticles (SLN) were labeled with a fluorescent phospholipid to check whether C-6 uptake was associated with SLN incorporation into the cells. RESULTS Intact SLN were not incorporated into the cells, i.e., C-6 was passively redistributed from SLN to lipophilic cellular compartments. C-6 was enriched up to a given limit in HCE-T cells within 5 min of contact with the dispersions both under static and under flow conditions. The C-6 delivery rate from liposomes was superior to that from SLN whereby the suspension exhibited the lowest rate. C-6 release rates were comparable for static and flow conditions. Alternate flushing with formulations and buffer revealed that cells accumulated C-6. The results suggest that combining microfluidics with live cell imaging provides a valuable option for in vitro studies of ocular drug delivery.

[1]  Kamel Alhanout,et al.  Recent advances in ocular drug delivery , 2013, Drug development and industrial pharmacy.

[2]  R. Gurny,et al.  Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  O. Corrigan,et al.  Quantifying drug release from PLGA nanoparticulates. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  S. Tay,et al.  Microfluidic cell culture. , 2014, Current opinion in biotechnology.

[5]  M. Schubert,et al.  Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  S. Féry-Forgues,et al.  Fluorescent Microcrystals Obtained from Coumarin 6 Using the Reprecipitation Method , 2008, Journal of Fluorescence.

[7]  Quan Liu,et al.  Development of an Ex Vivo Method for Evaluation of Precorneal Residence of Topical Ophthalmic Formulations , 2009, AAPS PharmSciTech.

[8]  Christel C Müller-Goymann,et al.  Controlling solid lipid nanoparticle adhesion by polyelectrolyte multilayer surface modifications. , 2013, International journal of pharmaceutics.

[9]  Sephra N. Rampersad,et al.  Multiple Applications of Alamar Blue as an Indicator of Metabolic Function and Cellular Health in Cell Viability Bioassays , 2012, Sensors.

[10]  Tal Dvir,et al.  Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. , 2011, Biomaterials.

[11]  K. Dawson,et al.  Elution of Labile Fluorescent Dye from Nanoparticles during Biological Use , 2011, PloS one.

[12]  Tingrui Pan,et al.  Microfluidic System for Facilitated Quantification of Nanoparticle Accumulation to Cells Under Laminar Flow , 2012, Annals of Biomedical Engineering.

[13]  Michael Wirth,et al.  An acoustically-driven biochip - impact of flow on the cell-association of targeted drug carriers. , 2009, Lab on a chip.

[14]  M. Thiel,et al.  A simple corneal perfusion chamber for drug penetration and toxicity studies , 2001, The British journal of ophthalmology.

[15]  H. Edelhauser,et al.  Ocular drug delivery , 2006, Expert opinion on drug delivery.

[16]  A. von Mikecz,et al.  Defining the Subcellular Interface of Nanoparticles by Live-Cell Imaging , 2013, PloS one.

[17]  S. Venkatraman,et al.  High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds. , 2011, Journal of pharmaceutical sciences.

[18]  K. Nguyen,et al.  Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. , 2012, International journal of pharmaceutics.

[19]  Kapil Pant,et al.  A physiologically realistic in vitro model of microvascular networks , 2009, Biomedical microdevices.

[20]  M. Brandl,et al.  Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. , 2001, International journal of pharmaceutics.

[21]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[22]  A. Zeiher,et al.  Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. , 1998, Circulation research.

[23]  Maria Jose Alonso,et al.  Chitosan-based nanostructures: a delivery platform for ocular therapeutics. , 2010, Advanced drug delivery reviews.

[24]  Karsten Mäder,et al.  Solid lipid nanoparticles , 2012 .

[25]  S. Pääbo,et al.  Bonobos Fall within the Genomic Variation of Chimpanzees , 2011, PloS one.

[26]  Douglas J. Goetz,et al.  Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.

[27]  V. Oberle,et al.  Fluorescent lipid probes: some properties and applications (a review). , 2002, Chemistry and physics of lipids.

[28]  K. Dawson,et al.  Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells , 2012, Journal of Nanobiotechnology.

[29]  Takuya Fujisawa,et al.  Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration. , 2010, Investigative ophthalmology & visual science.

[30]  B. Luppi,et al.  Drug "supersaturation" states induced by polymeric micelles and liposomes: a mechanistic investigation into permeability enhancements. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  R Krull,et al.  Disposable parallel poly(dimethylsiloxane) microbioreactor with integrated readout grid for germination screening of Aspergillus ochraceus. , 2011, Biomicrofluidics.

[32]  S Reichl,et al.  Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.

[33]  Govind Rao,et al.  Comparison of Trypan Blue Dye Exclusion and Fluorometric Assays for Mammalian Cell Viability Determinations , 1993, Biotechnology progress.

[34]  R. Gurny,et al.  Cyclosporine A delivery to the eye: a pharmaceutical challenge. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[36]  T. Giorgio,et al.  Convective flow increases lipoplex delivery rate to in vitro cellular monolayers , 2005, Gene Therapy.

[37]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[38]  F. Hornero,et al.  A Three-Dimensional Human Atrial Model with Fiber Orientation. Electrograms and Arrhythmic Activation Patterns Relationship , 2013, PloS one.

[39]  J. Leeming Treatment of Ocular Infections with Topical Antibacterials , 1999, Clinical pharmacokinetics.

[40]  Hanry Yu,et al.  A practical guide to microfluidic perfusion culture of adherent mammalian cells. , 2007, Lab on a chip.

[41]  Frank F Bier,et al.  Construction of an artificial cell membrane anchor using DARC as a fitting for artificial extracellular functionalities of eukaryotic cells , 2012, Journal of Nanobiotechnology.

[42]  E. Mariani,et al.  Calcein-Acetyoxymethyl Cytotoxicity Assay: Standardization of a Method Allowing Additional Analyses on Recovered Effector Cells and Supernatants , 2001, Clinical Diagnostic Laboratory Immunology.

[43]  Alfred Fahr,et al.  Drug delivery strategies for poorly water-soluble drugs: the industrial perspective , 2011, Expert opinion on drug delivery.

[44]  Blair D. Johnson,et al.  Mechanotransduction of shear in the endothelium: Basic studies and clinical implications , 2011, Vascular medicine.

[45]  J. Kristl,et al.  A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells. , 2011, International journal of pharmaceutics.

[46]  H. Merkle,et al.  Transfer of Lipophilic Markers from PLGA and Polystyrene Nanoparticles to Caco-2 Monolayers Mimics Particle Uptake , 2002, Pharmaceutical Research.

[47]  J. Tiffany The viscosity of human tears , 1991, International Ophthalmology.

[48]  I. Zuhorn,et al.  Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis. , 2013, ACS nano.

[49]  S. Büttgenbach,et al.  The influence of customized geometries and process parameters on nanoemulsion and solid lipid nanoparticle production in microsystems , 2012 .

[50]  M. Masserini,et al.  Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. , 2011, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[51]  M. L. García,et al.  Validation of a device for transcorneal drug permeation measure. , 2008, Journal of pharmaceutical and biomedical analysis.

[52]  I. Kaur,et al.  Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.